Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab
Completed
Conditions studied: Diabetic Macular Edema
In brief
Patients with diabetic macular edema who were switched to aflibercept after having been treated with bevacizumab or ranibizumab were retrospectively reviewed to assess for visual acuity and anatomic outcomes.
Key facts
- Study ID
- NCT02000102
- Run by
- Stanford University
- People needed
- 14
- Starts
- 2013-09-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2014-11-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Byers Eye Institute at Stanford — Palo Alto, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.